phIL-12-005/PPC

· EGEN, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for phIL-12-005/PPC, covering 2013-02-28 to 2013-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer [Phase 1]